Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Repeated administration of antidepressant drugs to rodents produces adaptive changes in noradrenaline and 5-hydroxytryptamine pathways in the brain. A decrease in cortical beta-adrenoceptor binding is seen following most antidepressant treatments and is thought by some to be of importance in the therapeutic action of antidepressants; however, it seems equally plausible that this change simply reflects a homeostatic response to increased noradrenergic transmission. Another effect common to many different antidepressant treatments is an increase in neurotransmission through post-synaptic 5-HT1 receptors in some brain regions. 5-HT neuroendocrine studies suggest that this change also occurs in the human brain. Further investigations are required to assess whether alterations in 5-HT neurotransmissions are important in the therapeutic action of antidepressant treatment.


Journal article


Int Clin Psychopharmacol

Publication Date



5 Suppl 3


45 - 55


Aged, Animals, Antidepressive Agents, Arousal, Brain, Depressive Disorder, Humans, Receptors, Adrenergic, Receptors, Serotonin